These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 31409873)

  • 1. The inhibitory receptor CD94/NKG2A on CD8
    Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
    Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression.
    Bossard C; Bézieau S; Matysiak-Budnik T; Volteau C; Laboisse CL; Jotereau F; Mosnier JF
    Int J Cancer; 2012 Aug; 131(4):855-63. PubMed ID: 21953582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8
    Abd Hamid M; Wang RZ; Yao X; Fan P; Li X; Chang XM; Feng Y; Jones S; Maldonado-Perez D; Waugh C; Verrill C; Simmons A; Cerundolo V; McMichael A; Conlon C; Wang X; Peng Y; Dong T
    Cancer Immunol Res; 2019 Aug; 7(8):1293-1306. PubMed ID: 31213473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.
    Ducoin K; Oger R; Bilonda Mutala L; Deleine C; Jouand N; Desfrançois J; Podevin J; Duchalais E; Cruard J; Benlalam H; Labarrière N; Bossard C; Jarry A; Gervois-Segain N
    Oncoimmunology; 2022; 11(1):2046931. PubMed ID: 35295095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.
    Rosenbaum MW; Bledsoe JR; Morales-Oyarvide V; Huynh TG; Mino-Kenudson M
    Mod Pathol; 2016 Sep; 29(9):1104-12. PubMed ID: 27198569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.
    Sáez-Borderías A; Romo N; Magri G; Gumá M; Angulo A; López-Botet M
    J Immunol; 2009 Jan; 182(2):829-36. PubMed ID: 19124726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Density of FcγRIIIA
    Denis Musquer M; Jouand N; Pere M; Lamer JE; Bézieau S; Matysiak T; Faroux R; Caroli Bosc FX; Rousselet MC; Leclair F; Mosnier JF; Toquet C; Gervois N; Bossard C
    Front Oncol; 2021; 11():684478. PubMed ID: 34211852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Vetter CS; Straten PT; Terheyden P; Zeuthen J; Bröcker EB; Becker JC
    J Invest Dermatol; 2000 May; 114(5):941-7. PubMed ID: 10771475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
    Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.
    Gooden M; Lampen M; Jordanova ES; Leffers N; Trimbos JB; van der Burg SH; Nijman H; van Hall T
    Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10656-61. PubMed ID: 21670276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
    Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact.
    Na HY; Park Y; Nam SK; Lee KS; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    Cancer Sci; 2021 Jan; 112(1):91-100. PubMed ID: 33159376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions.
    Pace E; Di Sano C; Ferraro M; Tipa A; Olivieri D; Spatafora M; Santagata R; Bellia V; Gjomarkaj M
    Eur J Cancer; 2011 Jan; 47(2):296-304. PubMed ID: 20932742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
    Wischhusen J; Friese MA; Mittelbronn M; Meyermann R; Weller M
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):523-8. PubMed ID: 15977644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
    Deschoolmeester V; Baay M; Van Marck E; Weyler J; Vermeulen P; Lardon F; Vermorken JB
    BMC Immunol; 2010 Apr; 11():19. PubMed ID: 20385003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
    Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer.
    Sui Q; Liu D; Jiang W; Tang J; Kong L; Han K; Liao L; Li Y; Ou Q; Xiao B; Liu G; Ling Y; Chen J; Liu Z; Zuo Z; Pan Z; Zhou P; Zheng J; Ding PR
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33782107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.